Latest Choreia Stories
Results achieved over 80 weeks of treatment consistent with statistically significant reduction in chorea demonstrated in pivotal study.
NEW YORK, Aug. 15 /PRNewswire/ -- The Hereditary Disease Foundation (HDF) is extremely pleased the U.S. Food and Drug Administration has approved Xenazine, or tetrabenazine, for the treatment of chorea associated with Huntington's disease.
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.